Viewing Study NCT05972551


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2025-12-25 @ 9:31 PM
Study NCT ID: NCT05972551
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2023-07-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
Sponsor: Amgen
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-04-22
Start Date Type: ACTUAL
Primary Completion Date: 2027-06-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-08-25
Completion Date Type: ESTIMATED
First Submit Date: 2023-07-24
First Submit QC Date: None
Study First Post Date: 2023-08-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-10
Last Update Post Date: 2025-12-12
Last Update Post Date Type: ESTIMATED